ELOXATIN

Sanofi-aventis U.s. Llc

Application Filed: 2002-04-25

Trademark Application Details

Mark For: ELOXATIN® trademark registration is intended to cover the categories of pharmaceutical preparations, namely, an anti-cancer preparation, excluding use for the treatment of prostate cancer, for parenteral administration. [all]

Status

2022-07-26 UTC

LIVE REGISTRATION Issued and Active

The trademark application has been registered with the Office.

Research	OneLook Acronym Finder
Serial Number	76400845
Registration Number	2870847
Mark Literal Elements	ELOXATIN
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Affidavit Text	SECT 15. SECT 8 (6-YR). SECTION 8(10-YR) 20140823.
Affidavit Text	1ST RENEWAL 20140823
Current Location	GENERIC WEB UPDATE 2014-08-23
Basis	1(a)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Domestic Representative	Karen Lim
Attorney Name	Karen Lim
Attorney Docket Number	SAUS 0304428
Law Office Assigned	L50
Employee Name	CASE, LEIGH CAROLINE

Timeline

1ST RENEWAL 20140823	Renewal Date
2002-04-25	Application Filed
2002-08-30	Date of First Use
2002-08-30	Date of Use In Commerce
2004-05-18	Published
2004-05-18	Published for Opposition
2004-08-10	Trademark Registered
2014-08-10	Renewal Date
2014-08-23	Location: GENERIC WEB UPDATE
2014-08-23	Status: Live/Registered
2014-08-23	Status: The registration has been renewed.
2020-01-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	SANOFI-AVENTIS U.S. LLC
Address	55 CORPORATE DRIVE BRIDGEWATER, NEW JERSEY UNITED STATES 08807
Legal Entity Type	Limited Liability Company
Legal Entity State	DELAWARE

Documents

Application	IMAGE/TIFF	2002-04-25
Drawing	IMAGE/TIFF	2002-04-25
Duplicate Application		2002-04-25
Duplicate Drawing		2002-04-25
Evidence Outgoing		2002-08-23
Offc Action Outgoing		2002-08-23
XSearch Search Summary		2002-08-23
Paper Correspondence Incoming		2003-02-27
Response to Office Action		2003-02-27
Unclassified-Other		2003-03-27
Offc Action Outgoing	APPLICATION/XML	2003-05-07
Suspension Letter		2003-05-09
Change of Address	IMAGE/TIFF	2003-05-19
Paper Correspondence Incoming		2003-10-30
Statement of Use		2003-10-30
Paper Correspondence Incoming		2003-11-03
File Jacket		2003-11-24
Specimen		2003-11-24
Suspension Letter		2003-12-22
Notice of Acceptance of AAU		2003-12-23
Notice of Publication		2004-04-28
Registration Certificate	IMAGE/TIFF	2004-08-10
Section 8 and 15		2009-10-27
Specimen		2009-10-27
Notice of Acceptance Acknowledgement	APPLICATION/XML	2009-11-09
PR-Section 8 and 9		2014-08-05
Specimen		2014-08-05
Notice-Acceptance-Renewal	APPLICATION/XML	2014-08-23
Change of Address	IMAGE/JPEG	2017-01-31
Change of Address		2019-12-10

Attorney of Record

Karen Lim
Fross Zelnick Lehrman & Zissu, P.C.
151 WEST 42nd St.,17th Fl.
NEW YORK, New York 10036

Good, Services, and Codes

IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations, namely, an anti-cancer preparation, excluding use for the treatment of prostate cancer, for parenteral administration. FIRST USE: 20020830. FIRST USE IN COMMERCE: 20020830

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations, namely, an anti-cancer preparation, excluding use for the treatment of prostate cancer, for parenteral administration

Trademark Filing History

Description	Date	Proceeding Number
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED	2020-01-08
CORRESPONDENCE RECEIVED IN LAW OFFICE	2019-12-10
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED	2017-04-05	88889
CORRESPONDENCE RECEIVED IN LAW OFFICE	2017-01-31
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)	2014-08-23	67603
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED	2014-08-23	67603
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED	2014-08-23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2014-08-22	67603
TEAS SECTION 8 & 9 RECEIVED	2014-08-05
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.	2009-11-09	67723
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2009-11-06	67723
TEAS SECTION 8 & 15 RECEIVED	2009-10-27
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2006-11-29
REGISTERED-PRINCIPAL REGISTER	2004-08-10
PUBLISHED FOR OPPOSITION	2004-05-18
NOTICE OF PUBLICATION	2004-04-28
APPROVED FOR PUB - PRINCIPAL REGISTER	2004-02-26
LETTER OF SUSPENSION MAILED	2003-12-29
USE AMENDMENT ACCEPTED	2003-12-22
AMENDMENT TO USE PROCESSING COMPLETE	2003-12-05
CASE FILE IN TICRS	2003-11-25
SEC. 44(E) CLAIM DELETED	2003-11-03	78756
PAPER RECEIVED	2003-11-03
CORRESPONDENCE RECEIVED IN LAW OFFICE	2003-11-03
CORRESPONDENCE RECEIVED IN LAW OFFICE	2003-10-31
USE AMENDMENT FILED	2003-10-30
PAPER RECEIVED	2003-10-30
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2003-05-19
LETTER OF SUSPENSION MAILED	2003-05-09
PAPER RECEIVED	2003-02-27
CORRESPONDENCE RECEIVED IN LAW OFFICE	2003-02-27
NON-FINAL ACTION MAILED	2002-08-23
ASSIGNED TO EXAMINER	2002-08-21	72146

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
ELOXATIN 76400845 2870847 Live/Registered	SANOFI-AVENTIS U.S. LLC 2002-04-25
ELOXATIN 74699249 not registered Dead/Abandoned	Sanofi 1995-07-10